Chemours
537 hedge funds and large institutions have $7.11B invested in Chemours in 2017 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 149 increasing their positions, 157 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
537
Holders Change
+38
Holders Change %
+7.62%
% of All Funds
12.2%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
112
Increased
149
Reduced
157
Closed
71
Calls
$80.2M
Puts
$86.9M
Net Calls
-$6.68M
Net Calls Change
-$20.7M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$1.02B |
| 2 |
2
BlackRock
New York
|
$882M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$297M |
| 4 |
N
4
Natixis
Paris,
France
|
$61.8M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$944M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$22.8M |
| 2 |
2
Norges Bank
Oslo,
Norway
|
$82.5M |
| 3 |
3
Two Sigma Investments
New York
|
$1.71M |
| 4 |
4
Renaissance Technologies
New York
|
$152M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$32.4M |
